Skip to main content
OpenTrials

Clinical trial condition

Marginal Zone Lymphoma(MZL)

Explore clinical trials studying Marginal Zone Lymphoma(MZL). Study availability and eligibility vary by location and protocol.

13 public trials 7 recruiting studies

Marginal Zone Lymphoma(MZL) trial results

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Shanghai Ruijin Hospital Shanghai, China
  • Affiliated First Hospital of China Medical University Shenyang, Liaoning, China
  • Peking University Third Hospital Beijing, China
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
  • Dongyang People's Hospital Dongyang, China
  • Affiliated Hangzhou First People's Hospital Hangzhou, China
  • Zhejiang cancer Hospital Hangzhou, China
View all 18 locations
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • AOU SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • IRCCS-AOU di Bologna Bologna, Italy
  • P.O. Garibaldi-Nesima_UOC Ematologia Catania, Italy
  • AO di Cosenza, P.O. "Annunziata" - UOC di Ematologia Cosenza, Italy
View all 15 locations
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations
  • Samsung Medical Center Seoul, Gangnam-gu, South Korea
  • Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
  • Seoul National University Hospital Seoul, Jongno-gu, South Korea
  • The Catholic University of Korea Seoul, Seocho-gu, South Korea